13 Results

People

  1. Livingston
    Livingston
  2. Ragupathi
    Ragupathi
  3. Lloyd
    Lloyd
  4. Zhang
    Zhang
  5. Adluri
    Adluri
  6. Danishefsky
    Danishefsky
  7. Helling
    Helling
  8. Aghajanian
    Aghajanian
  9. Bornmann
    Bornmann
  10. Brady
    Brady

Groups

  1. Melanoma Disease Management Team (13)
  2. Department of Medicine (8)
  3. Melanoma and Immunotherapeutics Service (8)
  4. Solid Tumor Oncology Division (8)
  5. Hematologic Malignancies, Division of (2)
  6. Molecular Pharmacology and Chemistry Program Faculty (2)
  7. Sloan Kettering Institute Faculty (2)
  8. Biostatistics Service (1)
  9. Epidemiology and Biostatistics (1)
  10. GDMT, Medicine (1)
  1. "human"
  2. "Melanoma Disease Management Team"
  3. "Cancer Immunology, Immunotherapy"
Formats
  1. Journal Article (13)
Groups
  1. Melanoma Disease Management Team (13)
  2. Department of Medicine (8)
  3. Melanoma and Immunotherapeutics Service (8)
  4. Solid Tumor Oncology Division (8)
  5. Hematologic Malignancies, Division of (2)
  6. Molecular Pharmacology and Chemistry Program Faculty (2)

More Groups

People
  1. Philip Livingston (9)
  2. Govindaswami Ragupathi (7)
  3. Kenneth Lloyd (4)
  4. Shengle Zhang (4)
  5. Friedhelm Helling (2)
  6. Samuel Danishefsky (2)

More People

Years
  1. 2023 (2)
  2. 2003 (1)
  3. 2000 (1)
  4. 1999 (1)
  5. 1998 (2)
  6. 1997 (3)

More Years

Publications
  1. Cancer Immunology, Immunotherapy (13)
Publishers
  1. Springer (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: A propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
    Journal Article

    Weber, J. S.; Poretta, T.; Stwalley, B. D.; Sakkal, L. A.; Du, E. X.; Wang, T.; Chen, Y.; Wang, Y.; Betts, K. A.; Shoushtari, A. N.
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Journal Article

    Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers
    Journal Article

    Ragupathi, G.; Koide, F.; Sathyan, N.; Kagan, E.; Spassova, M.; Bornmann, W.; Gregor, P.; Reis, C. A.; Clausen, H.; Danishefsky, S. J.; more...
    Cancer Immunology, Immunotherapy (2003)

    Fulltext@MSK | Save
  • CD4+ T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro
    Journal Article

    Brady, M. S.; Lee, F.; Petrie, H.; Eckels, D. D.; Lee, J. S.
    Cancer Immunology, Immunotherapy (2000)

    Fulltext@MSK | Save
  • Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells
    Journal Article

    Cappello, S.; Liu, N. X.; Musselli, C.; Brezicka, F. T.; Livingston, P. O.; Ragupathi, G.
    Cancer Immunology, Immunotherapy (1999)

    Fulltext@MSK | Save
  • Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: Towards the design of anticancer vaccines
    Journal Article

    Kudryashov, V.; Kim, H. M.; Ragupathi, G.; Danishefsky, S. J.; Livingston, P. O.; Lloyd, K. O.
    Cancer Immunology, Immunotherapy (1998)

    Fulltext@MSK | Save
  • FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten
    Journal Article

    Capurro, M.; Bover, L.; Portela, P.; Livingston, P.; Mordoh, J.
    Cancer Immunology, Immunotherapy (1998)

    Fulltext@MSK | Save
  • Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans
    Journal Article

    Livingston, P. O.; Ragupathi, G.
    Cancer Immunology, Immunotherapy (1997)

    Fulltext@MSK | Save
  • Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale
    Journal Article

    Livingston, P. O.; Zhang, S.; Lloyd, K. O.
    Cancer Immunology, Immunotherapy (1997)

    Fulltext@MSK | Save
  • Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies
    Journal Article

    Livingston, P.; Zhang, S.; Adluri, S.; Yao, T. J.; Graeber, L.; Ragupathi, G.; Helling, F.; Fleisher, M.
    Cancer Immunology, Immunotherapy (1997)

    Fulltext@MSK | Save